“We were curious whether a simple intervention could nudge people toward a stronger sense of self at work,” said Thomas Sy, ...

Scientists have discovered a new mechanism that acts via an immune cell and points toward a different way of treating chronic ...

“This agreement is a long-term investment into securing the future of botanical drug innovation,” said Uttam Patil, Ph.D., Chief Executive Officer of ABVC. “By locking in upstream resources in Asia, ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...